Nelarabine Combination Therapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Lymphoma/Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nelarabine Combination Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Lymphoma/Leukemia
Blood Adv 2022 Dec 12;[EPub Ahead of Print], S Shimony, Y Liu, YK Valtis, JD Paolino, AE Place, AM Brunner, LD Weeks, LB Silverman, LM Vrooman, D Neuberg, RM Stone, DJ DeAngelo, MR LuskinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.